Park Ha Biological Technology is trading 5.95% down now at $2.37, with no clear company-specific catalyst identified for the September 8, 2026 decline.
- Auditor change effective September 1: HTL International appointed after WWC was terminated.
- The company reported no disagreements or reportable events.
- Broader sentiment was modestly negative, but available market moves do not clearly explain the stock’s sharper decline.